Cdk5 deregulation in the pathogenesis of Alzheimer's disease
- 1 September 2004
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 10 (9) , 452-458
- https://doi.org/10.1016/j.molmed.2004.07.001
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- The Relationship between Amyloid and TauJournal of Molecular Neuroscience, 2003
- The Cyclin-Dependent Kinase 5 Activators p35 and p39 Interact with the α-Subunit of Ca2+/Calmodulin-Dependent Protein Kinase II and α-Actinin-1 in a Calcium-Dependent MannerJournal of Neuroscience, 2002
- Calpain-mediated Cleavage of the Cyclin-dependent Kinase-5 Activator p39 to p29Journal of Biological Chemistry, 2002
- p35 and p39 Are Essential for Cyclin-Dependent Kinase 5 Function during NeurodevelopmentJournal of Neuroscience, 2001
- Neurotoxicity induces cleavage of p35 to p25 by calpainNature, 2000
- Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegenerationNature, 1999
- p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome PathwayJournal of Biological Chemistry, 1998
- An Isoform of the Neuronal Cyclin-dependent Kinase 5 (Cdk5) ActivatorJournal of Biological Chemistry, 1995
- A brain-specific activator of cyclin-dependent kinase 5Nature, 1994
- p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5Nature, 1994